fumigatus infections in mice at later time points. In conclusion, despite the recent advances in radiolabeled imaging techniques for invasive fungal infections, the search for better tracers for fungal infection imaging should be continued.
abstract
Invasive fungal infections are recognized as an important cause of morbidity and mortality in the immunocompromised host. Rapid initiation of adequate antifungal treatment is often hampered by the limitations of current diagnostic methods. This review encompasses the promises and limitations of newer tracers (believed to target the infectious agents), i.e. radiolabeled antimicrobial peptides, antifungals and chitin-specific agents, for fungal infection imaging by scintigraphy. In mice 99m Tc-labeled peptides derived from human ubiquicidin (UBI29-41) and lactoferrin (hLF1-11) distinguished local Candida albicans and Aspergillus fumigatus infections from sterile inflammatory processes, but not from bacterial infections.
Clinical trials showed that 99m
Tc-UBI29-41 can distinguish infectious from inflammatory lesions with 80% specificity and 100% sensitivity. Tc-hLF1-11 was able to monitor the antifungal effects of fluconazole on C. albicans infections. Moreover, Tc-fluconazole proved to be an excellent tracer for C. albicans infections as it did not accumulate in bacterial infections and inflammatory processes. However this tracer poorly detected A. fumigatus infections.
Furthermore, 123 I-chitinase and
Introduction
Positive blood cultures have remained the gold standard for the diagnosis of invasive candidiasis, a condition still associated with high morbidity and mortality [1] . Whether attempted treatment is successful depends on the choice of the antifungal agent and duration of therapy as well as on the elimination of the primary focus [2] . However, patients may have no evident clinical signs or symptoms pointing to the origin of the candidemia or new foci that developed through hematogenous spread. In general, intravascular catheters are most frequently involved as a primary or maintaining focus of candidemia and should then promptly be removed [3, 4] . In surgical patients, infection with Candida spp. and subsequent candidemia can be related to the type and site of operation, e.g. intra-abdominal abscesses, mediastinitis, vascular grafts or joint prosthesis. In patients with hematological disorders requiring treatment with bone-marrow transplantation or intensive chemotherapy fungal infections may originate from the gastro-intestinal tract, where the growth of yeasts like C.
albicans is restricted by the microbial flora, the actions of host's immune defenses, and other local environmental conditions. Disturbance of this balance in severely immunocompromised patients, e.g. loss of the gastro-intestinal mucosal integrity and neutrophil depletion [5] , can result in uncontrolled growth of C. albicans and lead to invasion of deeper mucosal tissue or dissemination to other organs [6] . Due to an increase in the numbers of these patients it can be anticipated that the absolute number of patients with invasive candidiasis is increasing.
It is often a major challenge for clinicians to determine the primary focus of the infection, the extent of dissemination or whether the surgical site is involved. Important clinical consequences may include extended antifungal treatment, abscess drainage or even removal of the graft or prosthesis [2, 7, 8] . Currently available techniques such as ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are anatomically oriented.
These are highly sensitive and sophisticated, yet lack specificity for infection, especially in early phases, when anatomic structures have not been altered. Difficulties in purifying natural antimicrobial peptides from various sources have prompted the recombinant production of antimicrobial peptides by genetically engeneered bacteria [35] or by peptide synthesis [36, 37] . Sufficient amounts of antimicrobial peptides can be produced under good laboratory practice conditions. The latter is essential for future ap- To overcome the disadvantage that UBI-derived and lactoferrin-derived peptides (as well as other antimicrobial peptides) exerting their antimicrobial activities and thus destroying their targets for infection imaging, these peptides were used for scintigraphic studies at doses lacking microbicidal activity [42] .
Box 1.

Key features of antimicrobial peptides
 Antimicrobial peptides usually contain < 50 amino acids with a net positive charge owing to an excess of basic residues, such as lysine and arginine, and ~ 50% hydrophobic amino acids.

The majority of antimicrobial peptides are derived from larger precursors harboring a signal sequence, whereas other peptides are generated by proteolysis from larger proteins (such as lactoferricin).
 Antimicrobial peptides are part of the chemical barrier against the constant microbial assault found at various anatomical sites, such as epithelia [17] .
The expression of antimicrobial peptides by cells may be constitutive or induced upon contact with microorganisms or their products, like LPS, or pro-inflammatory cytokines.
 Most antimicrobial peptides can affect both planktonic bacteria and those residing in biofilms [18, 19] , viruses such as HIV [20] , and fungi [21] in vitro [22] [23] [24] [25] and in laboratory animals [26, 28] .
 In addition to their antimicrobial actions, antimicrobial peptides such as -and -defensins, cathelicidins (LL-37), and lactoferrin-derived peptides, participate at the interface of innate and adaptive immunity by modulating cytokine and chemokine production by a range of cell types, chemoattracting various immune effector cells [29] and mesenchymal stem cells [30] , regulating autophagy in conjunction with vitamin D [31] , modulating the differentiation of monocytes to macrophages [32] and dendritic cells [33] and stimulating angiogenesis and wound healing [34] . azole compounds are induced to a respiratory deficient "petite" status at a high frequency [43] . A further role of ergosterol can be found in mating conditions as demonstrated by mutations in ERG4, encoding the enzyme that catalyzes the last step of ergosterol biosynthesis that impair both shmoo formation and cell fusion [44] .
Radiolabeling of antimicrobial peptides and fluconazole
Obligatory conditions for adequate radiolabeling include the firm attachment of radionu- Tc, such as the indirect labeling using the preformed chelate approach or bifunctional chelating agents and the direct labeling method, have been extensively discussed [11, 45] . The radiolabeled tracer obtained with the preformed chelate approach is chemically well-defined as the 99m Tc is bound to the specific chelating moiety before incubation with the peptide, thereby not exposing the compound to harsh labeling conditions. The drawbacks of this method are that it is complex and not well-suited for kit formulation. The use of bifunctional chelating agents incorporated into the peptide molecules, like HYNIC, N 3 S, DADT, amongst others, is chemically well-defined. However, introduction of a chelator may alter the lipophilicity of the peptide and thus its pharmacokinetics. Moreover, the large amounts of these chelating agents used to achieve high peptide-chelator conjugation yields require a time-consuming Chapter 8 purification step. The direct labeling method is, however, a simple procedure that has been used to successfully label an array of peptides and antibiotics, e.g. ciprofloxacin [46] and fluconazole [47] , while keeping their biological functions intact [48] . This labeling method is performed under reducing conditions at a final pH 5-6 and requires a relatively short labeling time of approximately 10-20 min, resulting in a high labeling yield over 95% [41] . The stability of the 99m Tc-peptide/fluconazole complex in diluted human serum was excellent, and the peptides/anti-infectives retained their antimicrobial activity towards microorganisms in in vitro killing assays [41, 42, 49, 50] . In the reaction mixtures no colloids or free radioactive pertechnetate exceeding 5% of the total 99m
Tc-activity were observed [41] .
In vitro binding studies and scintigraphic detection of infections by 99m
Tc-labeled antimicrobial peptides/fluconazole
A first selection of peptides displaying a preferential binding to fungi and bacteria over activated human leukocytes was performed by testing in vitro an array of 99m Tc-labeled synthetic peptides derived from natural human antimicrobial peptides, e.g. UBI and hLF [40, 49, 50] .
The most promising peptides were Table 1 .
Following these investigations, 99m
Tc-peptides and 99m Tc-fluconazole were injected into mice with a bacterial or fungal infection or sterile inflammatory process in order to study whether they could discriminate infections from sterile inflammatory lesions using scintigraphic techniques. Scintigraphic analysis revealed that these 99m Tc-tracers accumulated at sites of infection, but not inflammation (Figure 1) . The results are expressed as the ratio between In vitro binding of the amount of radioactivity in the infected or infl amed (target) and the non-infected or non-infl amed (non-target) thighs, further referred as to target-to-non-target (T/NT) ratio. Tc-human polyclonal IgG, which accumulates nonspecifi cally at sites of both infection and infl ammation, was used as positive control. The radiolabeled antimicrobial peptides accumulated rapidly (within 30 min) in the target (infected) tissues (1-2% of the injected dose) with little accumulation at sites of sterile infl ammation, indicating that fungal and bacterial infections can be distinguished from sterile infl ammation by these tracers [47, 50] . After killing the animals, the number of viable microorganisms was assessed in homogenized infected thigh muscles using microbiological techniques. Target-to-non-target ratios for the diff erent tracers are shown in Figure 1 .
In contrast to 
Biodistribution
Kinetic studies using intravenously injected Tc-tracers less suitable for the imaging of infectious foci in the abdomen (intra- Tc-UBI29-41 discriminates between bacterial infections and sterile inflammations in patients and confirmed that this tracer is without adverse effects.
Human biodistribution studies showed rapid clearance of 99m
Tc-UBI29-41 through the kidneys with gradual accumulation in the urinary bladder in time [54, 55] . Approximately 85% of the Tc-UBI29-41 is a highly sensitive and specific agent for localizing bacterial infected foci in various body districts and discriminating them from sterile inflammatory processes.
Newer radioligands
In the attempt to develop new tracers that specifically detect fungal infections, components of fungal cell wall have been considered highly selective targets. Since chitin is a component of fungal cell wall, which is absent in mammalian cells, a radiolabeled marker for chitine, 123 I-chitinase was developed in order to bind specifically to fungal cells. Tc via the bifunctional chelating agent HYNIC as a novel radiopharmaceutical for fungal infection imaging [58] . The maximum uptake of 
